📊 DYNTQ Key Takeaways
Is DYNTQ a Good Investment? Thesis Analysis
Dynatronics is experiencing severe financial deterioration with contracting revenues (-15.8% YoY), persistent operating losses, and negative free cash flow generation. The company's tight liquidity position (1.07x current ratio, 0.50x quick ratio) combined with unprofitable operations and minimal cash reserves ($761.7K) creates substantial solvency concerns despite having no long-term debt.
Why Buy DYNTQ? Key Strengths
- Zero long-term debt eliminates refinancing risk
- Gross margin of 24.7% indicates some pricing power in core products
- Debt-free balance sheet provides theoretical flexibility for restructuring
DYNTQ Investment Risks to Consider
- Revenue declining significantly (-15.8% YoY) indicating loss of market share or demand weakness
- Negative operating cash flow (-$93.3K) means company is burning cash from operations
- Critical liquidity stress with quick ratio of 0.50x and only $761.7K cash against $11.9M liabilities
- Persistent net losses (-$2.9% margin) with deteriorating EPS (-43.0% YoY)
- Negative interest coverage ratio (-0.9x) indicates inability to cover obligations from operations
- Return metrics deeply negative (ROE -6.6%, ROA -1.3%) showing value destruction
Key Metrics to Watch
- Operating cash flow trend - continued negative FCF threatens liquidity survival
- Revenue stabilization - must halt 15.8% annual decline to validate business model
- Quick ratio and cash position - watch for liquidity crisis indicators below 0.40x or cash depletion
DYNTQ Financial Metrics
💡 AI Analyst Insight
DYNATRONICS CORP presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
DYNTQ Profitability Ratios
DYNTQ vs Healthcare Sector
How DYNATRONICS CORP compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is DYNTQ Overvalued or Undervalued?
Based on fundamental analysis, DYNATRONICS CORP has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
DYNTQ Balance Sheet & Liquidity
DYNTQ 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: DYNATRONICS CORP's revenue has declined by 48% over the 5-year period, indicating business contraction. The most recent EPS of $-1.00 indicates the company is currently unprofitable.
DYNTQ Growth Metrics (YoY)
DYNTQ Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $7.0M | -$201.9K | $-0.03 |
| Q3 2025 | $6.2M | -$667.7K | $-0.13 |
| Q3 2024 | $7.7M | -$667.7K | $-0.17 |
| Q2 2024 | $7.3M | -$774.8K | $-0.13 |
| Q1 2024 | $7.6M | -$330.7K | $-0.09 |
| Q3 2023 | $9.2M | $482.6K | $-0.36 |
| Q2 2023 | $8.2M | $482.6K | $-0.27 |
| Q1 2023 | $9.4M | -$330.7K | $-0.12 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
DYNTQ Capital Allocation
DYNTQ SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for DYNATRONICS CORP (CIK: 0000720875)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DYNTQ
What is the AI rating for DYNTQ?
DYNATRONICS CORP (DYNTQ) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are DYNTQ's key strengths?
Claude: Zero long-term debt eliminates refinancing risk. Gross margin of 24.7% indicates some pricing power in core products.
What are the risks of investing in DYNTQ?
Claude: Revenue declining significantly (-15.8% YoY) indicating loss of market share or demand weakness. Negative operating cash flow (-$93.3K) means company is burning cash from operations.
What is DYNTQ's revenue and growth?
DYNATRONICS CORP reported revenue of $7.0M.
Does DYNTQ pay dividends?
DYNATRONICS CORP does not currently pay dividends.
Where can I find DYNTQ SEC filings?
Official SEC filings for DYNATRONICS CORP (CIK: 0000720875) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DYNTQ's EPS?
DYNATRONICS CORP has a diluted EPS of $-0.03.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DYNTQ a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, DYNATRONICS CORP has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is DYNTQ stock overvalued or undervalued?
Valuation metrics for DYNTQ: ROE of -6.6% (sector avg: 15%), net margin of -2.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy DYNTQ stock in 2026?
Our dual AI analysis gives DYNATRONICS CORP a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is DYNTQ's free cash flow?
DYNATRONICS CORP's operating cash flow is $-93.3K, with capital expenditures of $296.0. FCF margin is -1.3%.
How does DYNTQ compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -2.9% (avg: 12%), ROE -6.6% (avg: 15%), current ratio 1.07 (avg: 2).